Lasting Prolonged-Release Tapentadol for Moderate/Severe Non-Cancer Musculoskeletal Chronic Pain

INTRODUCTION: Despite opioids’ recognized role in the treatment of moderate/severe musculoskeletal chronic pain, their long-term benefits need investigation. We explored the lasting analgesic efficacy, tolerability, influence on life quality, and chronicity stage of the novel prolonged release (PR)...

Descripción completa

Detalles Bibliográficos
Autores principales: Samolsky Dekel, Boaz G., Ghedini, Sivia, Gori, Alberto, Vasarri, Alessio, Di Nino, GianFranco, Melotti, Rita M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470964/
https://www.ncbi.nlm.nih.gov/pubmed/25558866
http://dx.doi.org/10.1007/s40122-014-0030-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470964/
https://www.ncbi.nlm.nih.gov/pubmed/25558866
http://dx.doi.org/10.1007/s40122-014-0030-6

Ejemplares similares